Skip to main content
QuidelOrtho Corp logo

QuidelOrtho Corp — Investor Relations & Filings

Ticker · QDEL ISIN · US2197981051 LEI · 549300YU8CMO9HF53113 US Manufacturing
Open in API
Filings indexed 398 across all filing types
Latest filing 2026-04-27 Annual Report
Country US United States of America
Listing US QDEL

About QuidelOrtho Corp

https://www.quidelortho.com/

QuidelOrtho Corp is a global developer and manufacturer of in vitro diagnostic products. The company provides a broad range of testing solutions that span the healthcare continuum, from clinical laboratories and hospitals to at-home consumer use. Its portfolio encompasses technologies in immunoassay, molecular diagnostics, clinical chemistry, and immunohematology. These products are designed to deliver fast, accurate, and reliable results for the detection and management of various health conditions, including infectious diseases such as COVID-19, influenza, HIV, and hepatitis C. QuidelOrtho focuses on transforming diagnostic data into actionable insights to improve patient outcomes.

Recent filings

Filing Released Lang Actions
ARS - QuidelOrtho Corp (0001906324) (Filer)
Annual Report
2026-04-27 English
8-K - QuidelOrtho Corp (0001906324) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 18, 2026, reporting the departure and appointment of certain officers: the retirement of the Chief Legal Officer and Corporate Secretary and the appointment of a successor. The content focuses on management changes and related arrangements. There are no financial statements or detailed financial data presented. The primary subject is the change in senior management roles, which fits the category of Board/Management Information (MANG).
2026-03-24 English
10-K - QUIDELORTHO CORP (0001906324) (Filer)
Annual Report FY 2025
2026-02-19 English
8-K - QUIDELORTHO CORP (0001906324) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The key content is the announcement of the retirement of the Chief Financial Officer, Joseph M. Busky, effective June 30, 2026. This is a change in senior management. The document does not contain financial statements or detailed financial analysis, nor is it an earnings release or annual report. It specifically relates to a departure of a director or officer, which fits the category of Board/Management Information (MANG). The document length is short (3100 characters), consistent with a typical 8-K announcement of management changes. Therefore, the correct classification is MANG with high confidence.
2026-02-13 English
4 - QUIDELORTHO CORP (0001906324) (Filer)
Director's Dealing
2026-02-13 English
4 Filing
Director's Dealing
2026-02-13 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.